These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 7138066)

  • 41. [Conditions and limitations of healthy carrier screening for the mutation responsible for cystic fibrosis].
    Serre JL; Feingold J
    Rev Epidemiol Sante Publique; 1993; 41(5):353-62. PubMed ID: 8284475
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cystic fibrosis: community knowledge and attitudes towards carrier screening and prenatal diagnosis.
    Decruyenaere M; Evers-Kiebooms G; Denayer L; Van den Berghe H
    Clin Genet; 1992 Apr; 41(4):189-96. PubMed ID: 1576756
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Clinical aspects, diagnosis and genetics of cystic fibrosis--a short review].
    Szibor R; Gedschold J; Steinbicker V
    Z Arztl Fortbild (Jena); 1988; 82(22):1162-6. PubMed ID: 2907837
    [No Abstract]   [Full Text] [Related]  

  • 44. Present state of DNA-diagnosis for cystic fibrosis and attitudes concerning a heterozygote screening in the GDR.
    Coutelle C; Grade K; Speer A; Will K; Gille C; Szibor R; Gedschold J; Brückner R; Steinbicker V; Bauer I
    Adv Exp Med Biol; 1991; 290():75-8; discussion 78-81. PubMed ID: 1950759
    [No Abstract]   [Full Text] [Related]  

  • 45. Cystic fibrosis carrier testing in early pregnancy by general practitioners.
    Harris H; Scotcher D; Hartley N; Wallace A; Craufurd D; Harris R
    BMJ; 1993 Jun; 306(6892):1580-3. PubMed ID: 8329921
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Community-wide screening for cystic fibrosis carriers could replace newborn screening for the diagnosis of cystic fibrosis.
    Wilcken B
    J Paediatr Child Health; 2008 Apr; 44(4):232-3; author reply 233. PubMed ID: 18377372
    [No Abstract]   [Full Text] [Related]  

  • 47. PCR-based cystic fibrosis (CF) carrier screening in a first-year medical student biochemistry laboratory.
    Grody WW; Kronquist KE; Lee EU; Edmond J; Rome LH
    Am J Hum Genet; 1993 Dec; 53(6):1352-5. PubMed ID: 8250051
    [No Abstract]   [Full Text] [Related]  

  • 48. Cost effectiveness of antenatal screening for cystic fibrosis.
    Cuckle HS; Richardson GA; Sheldon TA; Quirke P
    BMJ; 1995 Dec; 311(7018):1460-3; discussion 1463-4. PubMed ID: 8520332
    [TBL] [Abstract][Full Text] [Related]  

  • 49. General population screening for cystic fibrosis is premature.
    Biesecker L; Bowles-Biesecker B; Collins F; Kaback M; Wilfond B
    Am J Hum Genet; 1992 Feb; 50(2):438-9. PubMed ID: 1734723
    [No Abstract]   [Full Text] [Related]  

  • 50. An evaluation of population screening for carriers of cystic fibrosis.
    Smith MJ
    J Public Health Med; 1992 Sep; 14(3):257-63. PubMed ID: 1419203
    [No Abstract]   [Full Text] [Related]  

  • 51. Whole-population screening for carriers of cystic fibrosis gene.
    Carswell F
    Lancet; 1996 May; 347(9013):1421-2. PubMed ID: 8676620
    [No Abstract]   [Full Text] [Related]  

  • 52. "Suddenly Having two Positive People who are Carriers is a Whole New Thing" - Experiences of Couples Both Identified as Carriers of Cystic Fibrosis Through a Population-Based Carrier Screening Program in Australia.
    Ioannou L; Delatycki MB; Massie J; Hodgson J; Lewis S
    J Genet Couns; 2015 Dec; 24(6):987-1000. PubMed ID: 25925605
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The ethics of cystic fibrosis carrier screening: where do we stand?
    De Braekeleer M; Mélançon MJ
    Am J Hum Genet; 1990 Sep; 47(3):580-1. PubMed ID: 2393029
    [No Abstract]   [Full Text] [Related]  

  • 54. To test or not to test?
    Roberts L
    Science; 1990 Jan; 247(4938):17-9. PubMed ID: 2294585
    [No Abstract]   [Full Text] [Related]  

  • 55. The cost-effectiveness of prenatal carrier screening for cystic fibrosis.
    Lieu TA; Watson SE; Washington AE
    Obstet Gynecol; 1994 Dec; 84(6):903-12. PubMed ID: 7970468
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Prenatal, neonatal and postnatal prevention in cystic fibrosis].
    Frézal J; Briard ML; Farriaux JP
    Bull Acad Natl Med; 1993 Mar; 177(3):405-11; discussion 412. PubMed ID: 8364746
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of public health strategies on the birth prevalence of cystic fibrosis in Brittany, France.
    Scotet V; Audrézet MP; Roussey M; Rault G; Blayau M; De Braekeleer M; Férec C
    Hum Genet; 2003 Aug; 113(3):280-5. PubMed ID: 12768409
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antenatal screening for cystic fibrosis: a trial of the couple model.
    Livingstone J; Axton RA; Gilfillan A; Mennie M; Compton M; Liston WA; Calder AA; Gordon AJ; Brock DJ
    BMJ; 1994 Jun; 308(6942):1459-62. PubMed ID: 8019277
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Towards an improved antenatal screening for cystic fibrosis].
    Serre JL; Feingold J; Simon-Bouy B; Muller F
    Rev Epidemiol Sante Publique; 2003 Apr; 51(2):245-53. PubMed ID: 12876510
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Feasibility study of community control programmes for cystic fibrosis: memorandum from a WHO/ICF(M)A meeting.
    Bull World Health Organ; 1990; 68(6):709-15. PubMed ID: 2073710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.